NO20083303L - Fremgangsmater, sammensetinger og sett for behandling av muskel-skjelettsykdommer og symptomer assosiert dermed - Google Patents
Fremgangsmater, sammensetinger og sett for behandling av muskel-skjelettsykdommer og symptomer assosiert dermedInfo
- Publication number
- NO20083303L NO20083303L NO20083303A NO20083303A NO20083303L NO 20083303 L NO20083303 L NO 20083303L NO 20083303 A NO20083303 A NO 20083303A NO 20083303 A NO20083303 A NO 20083303A NO 20083303 L NO20083303 L NO 20083303L
- Authority
- NO
- Norway
- Prior art keywords
- compositions
- methods
- sets
- treating
- swelling
- Prior art date
Links
- 208000023178 Musculoskeletal disease Diseases 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 208000024891 symptom Diseases 0.000 title 1
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 abstract 4
- 206010053631 Bone swelling Diseases 0.000 abstract 2
- 239000002126 C01EB10 - Adenosine Substances 0.000 abstract 2
- 229960005305 adenosine Drugs 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 230000006735 deficit Effects 0.000 abstract 2
- JOZPEVMCAKXSEY-UHFFFAOYSA-N pyrimido[5,4-d]pyrimidine Chemical class N1=CN=CC2=NC=NC=C21 JOZPEVMCAKXSEY-UHFFFAOYSA-N 0.000 abstract 2
- 210000004872 soft tissue Anatomy 0.000 abstract 2
- 230000008961 swelling Effects 0.000 abstract 2
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 abstract 1
- 229960002768 dipyridamole Drugs 0.000 abstract 1
- 201000008482 osteoarthritis Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74317806P | 2006-01-26 | 2006-01-26 | |
| US78002806P | 2006-03-07 | 2006-03-07 | |
| US81565706P | 2006-06-22 | 2006-06-22 | |
| PCT/US2007/002224 WO2007089617A2 (en) | 2006-01-26 | 2007-01-25 | Methods, compositions, and kits for the treatment of musculoskeletal disorders and symptoms associated therewith |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20083303L true NO20083303L (no) | 2008-09-24 |
Family
ID=38327923
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20083303A NO20083303L (no) | 2006-01-26 | 2008-07-28 | Fremgangsmater, sammensetinger og sett for behandling av muskel-skjelettsykdommer og symptomer assosiert dermed |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20070213308A1 (de) |
| EP (1) | EP1999626A4 (de) |
| JP (1) | JP2009527465A (de) |
| KR (1) | KR20080089512A (de) |
| AU (1) | AU2007210044A1 (de) |
| CA (1) | CA2640484A1 (de) |
| IL (1) | IL193080A0 (de) |
| NO (1) | NO20083303L (de) |
| WO (1) | WO2007089617A2 (de) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003030823A2 (en) * | 2001-10-05 | 2003-04-17 | Combinatorx, Incorporated | Combinations for the treatment of immunoinflammatory disorders |
| TW200517114A (en) * | 2003-10-15 | 2005-06-01 | Combinatorx Inc | Methods and reagents for the treatment of immunoinflammatory disorders |
| WO2007139753A2 (en) * | 2006-05-22 | 2007-12-06 | Combinatorx, Incorporated | Methods and compositions for the treatment of diseases or conditions associated with increased c-reactive protein, interleukin-6, or interferon-gamma levels |
| US7811549B2 (en) * | 2006-07-05 | 2010-10-12 | Adenobio N.V. | Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects |
| MX2009004038A (es) | 2006-10-17 | 2009-08-24 | Nuvo Res | Gel de diclofenaco. |
| CA2737131A1 (en) * | 2007-09-19 | 2009-03-26 | Zalicus Inc. | Therapeutic regimens for the treatment of immunoinflammatory disorders |
| CA2709561A1 (en) * | 2007-12-17 | 2009-06-25 | Combinatorx, Incorporated | Therapeutic regimens for the treatment of immunoinflammatory disorders |
| US20090185973A1 (en) * | 2008-01-22 | 2009-07-23 | Adenobio N.V. | Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects |
| EP2337773A4 (de) * | 2008-08-13 | 2014-10-22 | Algometron Pty Ltd | Verfahren und vorrichtung zur bestimmung des schweregrades von schmerzen |
| US8870876B2 (en) | 2009-02-13 | 2014-10-28 | Tarsus Medical Inc. | Methods and devices for treating hallux valgus |
| US8546450B1 (en) | 2009-03-31 | 2013-10-01 | Nuvo Research Inc. | Treatment of pain with topical diclofenac compounds |
| US8618164B2 (en) | 2009-03-31 | 2013-12-31 | Nuvo Research Inc. | Treatment of pain with topical diclofenac compounds |
| US20100255086A1 (en) * | 2009-04-06 | 2010-10-07 | Yoel Ovil | Method for oral mucosal absorption of acetyl salycylic acid |
| US8277459B2 (en) | 2009-09-25 | 2012-10-02 | Tarsus Medical Inc. | Methods and devices for treating a structural bone and joint deformity |
| US8652141B2 (en) | 2010-01-21 | 2014-02-18 | Tarsus Medical Inc. | Methods and devices for treating hallux valgus |
| US8696719B2 (en) | 2010-06-03 | 2014-04-15 | Tarsus Medical Inc. | Methods and devices for treating hallux valgus |
| DK2613776T3 (da) | 2010-09-01 | 2020-10-19 | Univ Jefferson | Sammensætning og fremgangsmåde til muskelreparation og -regenerering |
| KR102255308B1 (ko) * | 2014-11-18 | 2021-05-24 | 삼성전자주식회사 | 아세틸살리실산을 포함하는 개체의 스테로이드 부작용을 예방 또는 치료하기 위한 조성물 및 그의 용도 |
| EA201890929A1 (ru) * | 2015-10-15 | 2018-09-28 | Моше Рогосницки | Низкие дозировки композиций дипиридамола для перорального приема и их использование |
| IL295440A (en) | 2016-06-08 | 2022-10-01 | Clementia Pharmaceuticals Inc | Methods for the treatment of heterotopic aggravation |
| KR101983654B1 (ko) * | 2018-07-24 | 2019-05-29 | 한국과학기술원 | Cfc 증후군 환자의 발달 저해를 완화할 수 있는 치료용 조성물 |
| CN114391506A (zh) * | 2021-12-24 | 2022-04-26 | 华中科技大学同济医学院附属协和医院 | 一种恢复节律促进骨组织生长发育的运动方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200517114A (en) * | 2003-10-15 | 2005-06-01 | Combinatorx Inc | Methods and reagents for the treatment of immunoinflammatory disorders |
| EP1689390B1 (de) * | 2003-11-21 | 2011-02-09 | Zalicus Inc. | Verfahren und reagenzien zur behandlung von entzündlichen erkrankungen |
-
2007
- 2007-01-25 KR KR1020087020807A patent/KR20080089512A/ko not_active Application Discontinuation
- 2007-01-25 AU AU2007210044A patent/AU2007210044A1/en not_active Abandoned
- 2007-01-25 JP JP2008552449A patent/JP2009527465A/ja active Pending
- 2007-01-25 WO PCT/US2007/002224 patent/WO2007089617A2/en active Application Filing
- 2007-01-25 US US11/698,240 patent/US20070213308A1/en not_active Abandoned
- 2007-01-25 CA CA002640484A patent/CA2640484A1/en not_active Abandoned
- 2007-01-25 EP EP07717066A patent/EP1999626A4/de not_active Withdrawn
-
2008
- 2008-07-27 IL IL193080A patent/IL193080A0/en unknown
- 2008-07-28 NO NO20083303A patent/NO20083303L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2007210044A1 (en) | 2007-08-09 |
| EP1999626A4 (de) | 2009-11-25 |
| IL193080A0 (en) | 2009-02-11 |
| US20070213308A1 (en) | 2007-09-13 |
| EP1999626A2 (de) | 2008-12-10 |
| CA2640484A1 (en) | 2007-08-09 |
| JP2009527465A (ja) | 2009-07-30 |
| KR20080089512A (ko) | 2008-10-06 |
| WO2007089617A3 (en) | 2008-06-12 |
| WO2007089617A2 (en) | 2007-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20083303L (no) | Fremgangsmater, sammensetinger og sett for behandling av muskel-skjelettsykdommer og symptomer assosiert dermed | |
| NO20083877L (no) | Sammensetninger og fremgangsmater for behandling av immunoinflammatoriske forstyrrelser | |
| Molassiotis et al. | A randomized, controlled trial of acupuncture self-needling as maintenance therapy for cancer-related fatigue after therapist-delivered acupuncture | |
| NO20075821L (no) | Fremgangsmate til a oke testosteron- og beslektede steroidkonsentrasjoner hos kvinner | |
| LTPA2017009I1 (lt) | Brutono tirozinkinazės inhibitoriai | |
| CY1117286T1 (el) | Μεσα και μεθοδοι για την αντιμετωπιση μυϊκων διαταραχων | |
| CY1118377T1 (el) | Syk αναστολεις ιμιδαζοπυραζινης | |
| RS20150135A1 (en) | TREATMENT WITH ANTI-VEGF ANTIBODIES | |
| Zhang et al. | Functional outcomes and health-related quality of life in fracture victims 27 months after the Sichuan earthquake | |
| EA200900203A1 (ru) | Избирательные модуляторы рецептора андрогенов, их аналоги, производные и применение | |
| NO20083202L (no) | ANG2- og VEFG-inhibitorkombinasjoner | |
| AR071732A1 (es) | Metodos para tratar la enfermedad de alzheimer, reducir la disminucion del volumen cerebral y monitorear una poblacion de pacientes que experimentan tratamiento o profilaxis para una enfermedad, uso de una medida de numero de copia apoe4, forma humanizada de un anticuerpo y acido nucleico aislado. | |
| EA201301078A1 (ru) | Новые терапевтические подходы в лечении смт и связанных с ней расстройств | |
| BRPI0410041A (pt) | métodos para tratamento de dor de cabeça de sinusite | |
| NO20092637L (no) | Fremgangsmater for behandling | |
| TW200630105A (en) | Herbal composition PHY906 and its use in chemotherapy | |
| NO20082473L (no) | Fremgangsmater, sammensetninger og sett for behandling av medisinske tilstander | |
| BRPI0908065A2 (pt) | Métodos para tratar um paciente que possui um ifn do tipo i ou doença ou distúrbio mediado por ifnalfa, para neutralizar um perfil de marcador mirna diferencialmente regulado em um paciente, para monitorar ou prognosticar uma progressão da doença inflamatória e da doença miosite de um paciente, para monitorar a progressão da doença inflamatória ou autoimune e da doença miosite de um paciente e para tratar um paciente com miosite | |
| EA201300213A1 (ru) | Применение ингибиторов dpp iv | |
| BR112014007675A2 (pt) | tratamento de doença articular degenerativa | |
| SV2006002342A (es) | Terapia de antiogenesis para enfermedades autoinmunes en pacientes que tuvieron la terapia anterior interrumpida | |
| CY1111799T1 (el) | Καινουργιες μεθοδοι | |
| Fukushima et al. | Low‐intensity exercise therapy with high frequency improves physical function and mental and physical symptoms in patients with haematological malignancies undergoing chemotherapy | |
| BRPI0504758A (pt) | miméticos de interleucina-8 e métodos para usá-los em prevenção, tratamento, diagnóstico, e melhora dos sintomas de uma doença | |
| BR112022014911A2 (pt) | Composição de saúde articular e uso da mesma em mamíferos saudáveis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |